These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
501 related articles for article (PubMed ID: 12481257)
1. Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro. Hedlund TE; Johannes WU; Miller GJ Prostate; 2003 Jan; 54(1):68-78. PubMed ID: 12481257 [TBL] [Abstract][Full Text] [Related]
2. Prostatic fluid concentrations of isoflavonoids in soy consumers are sufficient to inhibit growth of benign and malignant prostatic epithelial cells in vitro. Hedlund TE; van Bokhoven A; Johannes WU; Nordeen SK; Ogden LG Prostate; 2006 Apr; 66(5):557-66. PubMed ID: 16372328 [TBL] [Abstract][Full Text] [Related]
3. Reduced isoflavone metabolites formed by the human gut microflora suppress growth but do not affect DNA integrity of human prostate cancer cells. Raschke M; Wähälä K; Pool-Zobel BL Br J Nutr; 2006 Sep; 96(3):426-34. PubMed ID: 16925846 [TBL] [Abstract][Full Text] [Related]
4. Effects of phytoestrogens on growth and DNA integrity in human prostate tumor cell lines: PC-3 and LNCaP. Mitchell JH; Duthie SJ; Collins AR Nutr Cancer; 2000; 38(2):223-8. PubMed ID: 11525601 [TBL] [Abstract][Full Text] [Related]
5. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones. Guo Y; Wang S; Hoot DR; Clinton SK J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033 [TBL] [Abstract][Full Text] [Related]
6. Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice. Ju YH; Fultz J; Allred KF; Doerge DR; Helferich WG Carcinogenesis; 2006 Apr; 27(4):856-63. PubMed ID: 16399773 [TBL] [Abstract][Full Text] [Related]
7. Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products. Hutchins AM; Slavin JL; Lampe JW J Am Diet Assoc; 1995 May; 95(5):545-51. PubMed ID: 7722188 [TBL] [Abstract][Full Text] [Related]
8. Combination of low dose of genistein and daidzein has synergistic preventive effects on isogenic human prostate cancer cells when compared with individual soy isoflavone. Dong X; Xu W; Sikes RA; Wu C Food Chem; 2013 Dec; 141(3):1923-33. PubMed ID: 23870911 [TBL] [Abstract][Full Text] [Related]
9. The effect of the phytoestrogens genistein, daidzein, and equol on the growth of tamoxifen-resistant T47D/PKC alpha. Tonetti DA; Zhang Y; Zhao H; Lim SB; Constantinou AI Nutr Cancer; 2007; 58(2):222-9. PubMed ID: 17640169 [TBL] [Abstract][Full Text] [Related]
10. Isoflavonoid levels in spot urine are associated with frequency of dietary soy intake in a population-based sample of middle-aged and older Chinese in Singapore. Seow A; Shi CY; Franke AA; Hankin JH; Lee HP; Yu MC Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):135-40. PubMed ID: 9488588 [TBL] [Abstract][Full Text] [Related]
11. Effects of genistein and structurally related phytoestrogens on cell cycle kinetics and apoptosis in MDA-MB-468 human breast cancer cells. Balabhadrapathruni S; Thomas TJ; Yurkow EJ; Amenta PS; Thomas T Oncol Rep; 2000; 7(1):3-12. PubMed ID: 10601582 [TBL] [Abstract][Full Text] [Related]
12. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Muthyala RS; Ju YH; Sheng S; Williams LD; Doerge DR; Katzenellenbogen BS; Helferich WG; Katzenellenbogen JA Bioorg Med Chem; 2004 Mar; 12(6):1559-67. PubMed ID: 15018930 [TBL] [Abstract][Full Text] [Related]
13. Bioavailability and urinary excretion of isoflavones in humans: effects of soy-based supplements formulation and equol production. Vergne S; Titier K; Bernard V; Asselineau J; Durand M; Lamothe V; Potier M; Perez P; Demotes-Mainard J; Chantre P; Moore N; Bennetau-Pelissero C; Sauvant P J Pharm Biomed Anal; 2007 Mar; 43(4):1488-94. PubMed ID: 17110073 [TBL] [Abstract][Full Text] [Related]
14. Soy isoflavones augment the effect of TRAIL-mediated apoptotic death in prostate cancer cells. Szliszka E; Krol W Oncol Rep; 2011 Sep; 26(3):533-41. PubMed ID: 21637922 [TBL] [Abstract][Full Text] [Related]
15. Effects of phytoestrogens on the trophoblast tumour cell lines BeWo and Jeg3. Plessow D; Waldschläger J; Richter DU; Jeschke U; Bruer G; Briese V; Friese K Anticancer Res; 2003; 23(2A):1081-6. PubMed ID: 12820351 [TBL] [Abstract][Full Text] [Related]
16. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Zava DT; Duwe G Nutr Cancer; 1997; 27(1):31-40. PubMed ID: 8970179 [TBL] [Abstract][Full Text] [Related]
17. The potential of soybean foods as a chemoprevention approach for human urinary tract cancer. Su SJ; Yeh TM; Lei HY; Chow NH Clin Cancer Res; 2000 Jan; 6(1):230-6. PubMed ID: 10656454 [TBL] [Abstract][Full Text] [Related]
19. A comparative study of growth-inhibitory effects of isoflavones and their metabolites on human breast and prostate cancer cell lines. Xiang H; Schevzov G; Gunning P; Williams HM; Silink M Nutr Cancer; 2002; 42(2):224-32. PubMed ID: 12416264 [TBL] [Abstract][Full Text] [Related]
20. Molecular signatures of soy-derived phytochemicals in androgen-responsive prostate cancer cells: a comparison study using DNA microarray. Takahashi Y; Lavigne JA; Hursting SD; Chandramouli GV; Perkins SN; Kim YS; Wang TT Mol Carcinog; 2006 Dec; 45(12):943-56. PubMed ID: 16865672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]